Origin Pharma Packaging opens new UK warehouse in significant capacity expansion
New site includes warehouse maagement system which packaging firm claims will increase picking accuracy and efficiency
Origin Pharma Packaging has opened a new warehouse facility in Scunthorpe, UK, significantly expanding its overall storage capacity for pharmaceutical customers as well as its own manufactured products.
The new 86,000 sq. ft facility is set within a 5.9-acre site, houses 4,900 fully barcoded pallet spaces, a 20,000 sq. ft holding area and four loading bays and expands on Origin’s 25,000 sq. ft logistics warehouse in Melton, UK.
The facility – which Origin said is already fully functioning -- is also equipped with a Warehouse Management System, increasing pick accuracy, stock management and efficiency.
Origin said that by investing in larger warehouse capacity, it will be able to create a more efficient pharma packaging supply chain in the long term and protect against delays caused by the UK’s withdrawal from the European Union (Brexit) and the ongoing COVID-19 pandemic in the short term.
“It will also help the company serve a growing client base who are seeking ISO 15378 pharma standard storage space,” Origin said.
Pharmaceutical and medical device primary packaging materials – which include glass, rubber, plastics, aluminium containers/components, films, foils and laminate containers -- come in direct contact with medicinal products and so need to comply with safety, efficacy and reliability requirements, which include the conditions under which they are stored and transported.
The new warehouse is also supporting local job creation in North Lincolnshire, with Origin recruiting and expanding its on-site operation team. The warehouse is now fully functioning and all staff, along with visitors, are following strict COVID-19 rules and procedures – including social distancing, wearing PPE, temperature checks on arrival and track and trace.
“Origin’s new warehouse facility marks an important milestone for the company, supporting our ambitious growth plans and securing Origin’s long-term position as a market-leading partner to the UK and international pharmaceutical industry,” said Stewart Berry, Operations Lead at Origin.
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Understanding the Benefits and Advances of Cleanroom Technology
In an industry where precision and sterility are crucial concerns, cleanrooms play a vital role in maintaining the integrity of pharmaceutical products like drugs, vaccines, and other medical products. So, what is a cleanroom?
-
News From Pharma to Table? Direct-to-consumer pharma sales and price cuts ramp up in US
The pharmaceutical industry is witnessing a seismic shift as major companies embrace direct-to-consumer sales models and announce significant price reductions across the United States, responding to mounting pressure from the Trump administration to ta... -
News A Day in the Life of a Director of Business Development
In this Day in the Life of interview, Thomas Hauser, Director of Business Development at Tjoapack. Thomas has spent nearly 30 years in the pharmaceutical industry and describes how he still finds curiosity and excitement in the bigger picture of global... -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective.